118
- Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill The New York Times
- Hims & Hers pulls copycat weight-loss pill after threats of legal action CNBC
- Hims to stop offering GLP-1 pill after FDA warned of crackdown Reuters
- Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month investors.hims.com
- Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill ABC News
date:2026-02-07 23:19:00
Worth a look